Farwell A P, Leonard J L
Department of Nuclear Medicine, University of Massachusetts Medical School, Worcester 01655.
J Biol Chem. 1989 Dec 5;264(34):20561-7.
Type II iodothyronine 5'-deiodinase (5'D-II) catalyzes the intracellular conversion of thyroxine (T4) to 3,5,3'-triiodothyronine (T3), producing greater than 90% of the bioactive thyroid hormone in the cerebral cortex. In cultured glial cells, expression of this enzyme is cAMP dependent. Exploiting the cAMP-dependent nature of this enzyme in these cells and utilizing N-bromoacetyl-L-3'- or 5'-[125I]thyroxine (BrAc[125I]T4) to affinity label cellular proteins, a 27-kDa protein with the properties of this enzyme was identified. Intact cells labeled with BrAc[125I]T4 showed three prominent radiolabeled bands of proteins of Mr 55,000, 27,000, and 18,000 (p55, p27, p18, respectively) which incorporated approximately 80% of the affinity label. All three affinity-labeled proteins were membrane associated. One protein (p27) increased 5-6-fold after treating the cells for 16 h with dibutyryl cAMP; maximal specific incorporation of affinity label into the stimulated p27 was approximately 2 pmol/mg of cell protein in intact cells. Alterations in the steady-state levels of 5'D-II resulted in parallel changes in the quantity of p27. In cell sonicates, the rate of enzyme inactivation by BrAcT4 equaled the rate of affinity label incorporation into stimulated p27, whereas p55 and p18 showed little or no specific dibutyryl cAMP-stimulated labeling. Enzyme substrates T4 and 3,3'5'-triiodothyronine (rT3) specifically blocked p27 labeling, whereas T3 and the competitive 5'D-II inhibitor EMD 21388 (a synthetic flavonoid) were much less effective. Iopanoate, an inhibitor of all deiodinase isozymes, was ineffective in blocking p27 labeling. Inhibition kinetics revealed that iopanoate was a noncompetitive inhibitor of dibutyryl cAMP-stimulated glial cell 5'D-II, suggesting that it interacts at a site distant from the substrate-binding site. These data identify a cAMP-inducible membrane-associated protein (p27) that has many of the properties of 5'D-II.
II型碘甲状腺原氨酸5'-脱碘酶(5'D-II)催化甲状腺素(T4)在细胞内转化为3,5,3'-三碘甲状腺原氨酸(T3),在大脑皮层中产生超过90%的生物活性甲状腺激素。在培养的神经胶质细胞中,这种酶的表达是cAMP依赖性的。利用这些细胞中该酶的cAMP依赖性特性,并利用N-溴乙酰-L-3'-或5'-[125I]甲状腺素(BrAc[125I]T4)对细胞蛋白进行亲和标记,鉴定出一种具有该酶特性的27-kDa蛋白。用BrAc[125I]T4标记的完整细胞显示出三条明显的放射性标记蛋白带,分子量分别为55,000、27,000和18,000(分别为p55、p27、p18),它们结合了约80%的亲和标记。所有三种亲和标记蛋白都与膜相关。用二丁酰cAMP处理细胞16小时后,一种蛋白(p27)增加了5 - 6倍;在完整细胞中,亲和标记物对受刺激的p27最大特异性掺入量约为2 pmol/mg细胞蛋白。5'D-II稳态水平的改变导致p27数量的平行变化。在细胞超声裂解物中,BrAcT4使酶失活的速率等于亲和标记物掺入受刺激的p27的速率,而p55和p18几乎没有或没有特异性的二丁酰cAMP刺激标记。酶底物T4和3,3'5'-三碘甲状腺原氨酸(rT3)特异性地阻断p27标记,而T3和竞争性5'D-II抑制剂EMD 21388(一种合成类黄酮)的效果要差得多。碘番酸是所有脱碘酶同工酶的抑制剂,对阻断p27标记无效。抑制动力学表明,碘番酸是二丁酰cAMP刺激的神经胶质细胞5'D-II的非竞争性抑制剂,表明它在远离底物结合位点的位点相互作用。这些数据鉴定出一种具有许多5'D-II特性的cAMP诱导的膜相关蛋白(p27)。